Company / Revenue per Share
IMMUCELL CORP /DE/ Revenue per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.95
FY2025
5-year range
$1.97 / $3.35
FY2021-FY2025
Trend
+30.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $1.48 in FY2012 to $3.35 in FY2016.
Based on SEC 10-K filings.
2.95 in FY2025 with a 10-year CAGR of +4.2%.
Improved from $2.40 to $2.95 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +4.2%
Key checks
Key Insights
- In FY2025, revenue per share increased 30.9% year-over-year.
- Peak revenue per share was recorded in FY2016.
- Lowest revenue per share in the period was in FY2012.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.95 | +30.9% |
| FY2024 | $2.25 | -6.0% |
| FY2023 | $2.40 | +21.7% |
| FY2017 | $1.97 | -41.2% |
| FY2016 | $3.35 | +71.9% |
| FY2015 | $1.95 | +12.3% |
| FY2014 | $1.73 | +1.3% |
| FY2013 | $1.71 | +16.0% |
| FY2012 | $1.48 | -3.0% |
| FY2011 | $1.52 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026